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Themetabolic consequences of adiposity are dictated not only by ab-
solute adipose tissue (AT) mass but also by its distribution [1–5], to the
extent that waist-to-hip ratio (WHR) is a stronger predictor of myocar-
dial infarction than body mass index (BMI) [6]. Abdominal subcutane-
ous, visceral and gluteal femoral AT are structurally [7] and
functionally [8–10] distinct. WHR has heritability estimates ranging
from 40%–70% [11,12]. To date, the precise genetic mechanisms-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
Research in context
Evidence before this study
Body fat distribution is a strongpredictor ofmetabolic health, inde-
pendent of total adiposity. The role of microRNAs is regulating
body fat distribution has not been well defined.
Added value of this study
We demonstrate that miR-196a shows strong adipose depot-
specific expression patterns. A single nucleotide polymorphism
in pre-miR-196a-2 influences the expression of miR-196a in ab-
dominal subcutaneous adipose tissue and is associated with
waist-hip ratio. Furthermore, functional studies demonstrate that
miR-196a regulates pre-adipocyte proliferation and extracellular
matrix composition.
Implications of all the available evidence
Our study identifies a role for miR-196a in regulating human body
fat distribution. MicroRNAs hold potential as therapeutic targets
and biomarkers.
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within associated loci identified in genome-wide association studies ex-
plain only a small proportion of the phenotypic variance [13,14]. Other
biological factors, epigenetic amongst them and including tissue-
specific microRNAs (miRNA) [15], could explain an additional propor-
tion of phenotypic variation.2. Materials and methods
2.1. Human subject cohorts
2.1.1. Oxford Biobank (OBB)
The OBB is a cohort of apparently healthy 30–50-year old men and
women from Oxfordshire [16]. All volunteers in the OBB have under-
gone a comprehensive anthropomorphic and metabolic characterisa-
tion. ASAT biopsies were taken from the abdominal wall 2 in. lateral to
the umbilicus andGSAT biopsieswere taken from theupper outer quad-
rant of the buttock. Biopsies were obtained under local anaesthesia (1%
lignocaine) using a 12-gauge needle aspiration technique. Whole-body
DXA scanswere performed using a Lunar iDXA (GEHealthcare) and im-
ages were processed using enCORE v14.1 software (GE Healthcare). The
android region is defined by the iliac crest at the lower boundary and
the upper boundary is calculated as 20% of the distance between the
neck and the iliac crest. The gynoid region includes the upper thighs
and hips but does not overlap with the umbilicus. It is twice the height
of the android region with the upper boundary located below the iliac
crest by 1.5 times the height of the android region. VAT is calculated
by the encore v14.1 software using a predefined algorithm. Android
subcutaneousAT is calculated as total androidAT - VAT. Ethical approval
for studies involving OBB participants was granted by Oxfordshire Clin-
ical Research Ethics Committee (08/H0606/107) and all study partici-
pants have given written informed consent.2.1.2. Paired ASAT and VAT biopsies
Paired whole VAT and ASAT surgical biopsies were obtained from
sixteen Caucasian women (BMI 43∙1 (36∙9–47∙6) kg/m2, age 44∙5
(42∙8–48∙5) years)whowere undergoingbariatric surgery as previously
described [17].2.1.3. GIANT consortium
TheGIANT consortiumhas access to anthropometric and genotyping
data for nearly 250,000 individuals. Shungin et al [14] conducted a
meta-analysis of waist and hip circumference measurement associa-
tions, adjusted for age, BMI and study specific covariates, in individuals
of European ancestry using data from 57 GWAS studies. The p-values
were corrected using genomic control at the individual study level
and again after meta-analysis. Manhattan plots for the meta-analysis
are available here [14].
2.1.4. UK Biobank
The UK Biobank includes anthropometric, biochemical and genetic
data from N500,000 men and women recruited between 2006 and
2010 (REC 11/NW/0382). Further details are available elsewhere [18].
2.1.5. EPIC-Norfolk
The EPIC-Norfolk cohort includes 25,000men andwomenwhowere
aged between 40 and 79 at recruitment andwhounderwent DXA imag-
ing for body composition at the 20 year follow up assessment.
2.1.6. Fenland cohort
The Fenland Study is a population-based cohort study of the interac-
tion between genetics and environment in the development of diabetes
and obesity. The cohort contains a Cambridgeshire-based population of
men andwomenwithout diabetes born between 1950 and 1975. Partic-
ipants undergo detailed anthropometric andmetabolic characterisation
alongwith genotyping andDXAdetermination (GE Lunar iDXA) of body
composition as recently described [5].
2.1.7. Karolinska Institute cohorts
Genotyping and phenotypic data on fat cell size in ASAT was ob-
tained as described previously [19].
2.2. Primary cell cultures and region-specific human immortalised pre-
adipocyte cell lines
Primary pre-adipocytes were obtained by collagenase digestion of
minced whole AT biopsies. Volunteers for AT biopsy were recruited
from the OBB and were not included in other datasets involving OBB
subjects. For determination of miR-196a in fractionated AT the floating
adipocyte layer and stromal-vascular pellet were isolated after collage-
nase digestion and fractionation (n = 1). The imAPAD and imGPAD cell
lines have been described previously [20]. For cell culture experiments
pre-adipocytes were cultured in growth medium (Dulbecco's Eagle's
Medium Nutrient Mixture (DMEM)/F12 HAM (v/v, 1:1), 10% foetal
calf serum (FCS) (Invitrogen, Paisley, UK), 0.25 ng/ml fibroblast growth
factor (FGF), 100 U/ ml penicillin and 0.1 mg/ ml streptomycin). All cell
cultures were incubated at 37 °C with 5% CO2. To differentiate pre-
adipocytes, confluent cells were cultured for 14 days with differentia-
tion media (DMEM/F12 HAM (1:1) containing 2 mM glutamine, 17
μM pantothenate, 100 nM human insulin, 1 nM triiodo-L-thyronine
(T3), 33 μM biotin, 10 μg/ ml transferrin and 1 μM dexamethasone,
with the addition of 3-Isobutyl-1-methylxanthine (IBMX) (250 μM)
and troglitazone (4 μM) for the first 4 days).
Human Embryonic Kidney 293 (HEK293) cell lines were cultured in
growth media consisting of DMEM with 4500 mg/l glucose, 10% FCS,
2 mM glutamine, 100 U/ ml penicillin and 0.1 mg/ ml streptomycin.
2.3. Generation and culture of stable miR-196aKD cell lines
MISSION custom hsa-miR-196a-5p inhibitor [21] and ath-miR-416
negative control cloned into the TRC2-pLKO-puro vector were pur-
chased from Sigma-Aldrich (USA) in the form of DNA plasmids. Plas-
mids were amplified in MAX Efficiency DH5α Competent E. coli
(Invitrogen, UK). Amplified plasmids were isolated using the Midiprep
plasmid kit (Qiagen, UK).
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cells with the MISSION hsa-mir-196a-5p inhibitor or ath-miR-416 neg-
ative control vector along with packaging vectors (MISSION packaging
mix, Sigma-Aldrich, UK) using Fugene 6 (Promega, UK). To generate sta-
ble pre-adipocyte cell lines, imAPAD and imGPAD cell line pre-adipocytes
at passage 8were plated in T25flasks at a density of 1∙2x105cells/flask in
complete growthmedia. Cellswere transduced by culturing in complete
growth media with the addition of lentiviral particles and
hexadimethrine bromide at a final concentration of 8 μg/ml. Pre-
adipocyte cell lines were cultured in the presence of 2 μg/ml puromycin
during the proliferative phase but not after the addition of differentia-
tion media. The stable cell lines generated are referred to as imAPAD
mir-196aKD, imAPAD-Con, imGPADmir-196aKD and imGPAD-Con. Intra-
cellular lipid levels were quantified using the AdipoRed assay reagent
(Lonza) and a CytoFluor Multi-Well Plate Reader series 4000
(PerSeptive Biosystems). To calculate doubling time, pre-adipocytes
were seeded at equal density in T75 flasks andwere trypsinised and tri-
ple counted every 72 h.Doubling timewas calculatedusing the formula:
Doubling time = t2-t1 ((log [2]/log(q2/q1)).
where t = time (days) and q = cell number.
3. Method details
3.1. RNA extraction and quantification
RNAwas isolated fromTri-reagent. Formicroarray experiments RNA
was purified using MirVana Columns (Life Technologies). For other ex-
periments RNA was purified using a standard Tri-reagent protocol.
cDNAwas synthesised using themiScript kit (Qiagen). FormRNA quan-
tification qPCR was performed using Taqman Assays-on-Demand (Ap-
plied Biosystems) and Kapa Probe Fast Mastermix (Kapa Biosystems)
in a 6 μl final volume. For microRNA quantification Qiagen miScript
primer assays were used with the QuantiTect SYBR Green PCR Kit
(Qiagen, UK) in an 8 μl reaction. Gene expression was quantified using
theΔΔCTmethod [22]:mRNAwas quantified relative to the average ex-
pression of peptidylprolyl isomerase A (PPIA) and phosphoglycerate ki-
nase 1 (PGK1); miRNA and pre-miRNA abundance was quantified
relative to the average of miR-103, miR-24 and miR-331 [23]. Readings
of fluorescence detected during the qPCR reaction on the ABI Prism
7900HT were analysed using SDSv2.3 software (Life Technologies, UK).
3.2. Genotyping
Genomic DNA was extracted from whole blood by LGC Genomics
(Hoddesdon, UK). Genotyping in the OBB cohort was performed on
10 ng of DNA using KASP On Demand custom designed and validated
primers for rs11614913 (LGC Genomics, Hoddesdon, UK). Allelic dis-
crimination performed was on the ABI Prism 7900 HT Real-Time PCR
System (Life Technologies, UK) using SDSv2.3 software (Life Technolo-
gies, UK).
3.3. Western blotting
HEK293 cell lines transduced with miR-196a KD or control vector
were cultured in 6-well plates and then lysed by the addition of 150 μl
of lysis buffer (50 mM Tris pH 8.0, 250 mM NaCl, 5 mM EDTA, 0.5%
and Igepal CA-630). Normalised protein sampleswere resolved on a Cri-
terion Stain-Free precast gel (Bio-Rad, UK). Protein transfer onto a
polyvinylidene fluoride (PVDF) membrane was performed using the
Trans-Blot Turbo system (Bio-Rad, UK). The membrane was visualised
with the ChemiDoc MP system (Bio-Rad, UK) to quantify total protein
in each lane. The membrane was probed with HOXC8 rabbit polyclonal
antibody (ab86236 Abcam, RRID: AB_1925078) at a 1:1000 and 1:1000
goat anti-rabbit IgG horseradish peroxidase (HRP)-conjugated second-
ary antibodies (DAKO). An enhanced chemiluminescence (ECL) reac-
tion was performed using Clarity ECL substrate (Bio-Rad, UK) and wasvisualised using both the ChemiDoc MP and imaging film. HOXC8 was
quantified and normalised to total protein using Image Lab software
(Bio-Rad, UK).
3.4. Microarray of whole ASAT and GSAT
ASAT biopsies from 15 men (8 lean (BMI b 25) and 7 overweight
(BMI N 25)) and paired GSAT biopsies from 8 of the men (5 lean and 3
overweight) were hybridized to individual Agilent Human microRNA
Microarrays v2.0 (Agilent Technologies, Santa Clara, USA). The DNAmi-
croarray scanner (AgilentG2565BA)was used to scanhybridizedmicro-
arrays and features were extracted using the Agilent Feature Extraction
image analysis tool (version 9.5.1) with default protocols and settings.
Data were background corrected and quantile normalised in R [24]
using the Bioconductor AgiMicroRna package [25]. Differential expres-
sion analysis was performed in Genesifter (Geospiza, Seattle, USA)
with an uncorrected p-value of 0∙05 indicating significance. Aminimum
fold-change of 20% was selected to identify biologically important dif-
ferences in expression.
3.5. Microarray analysis of miR-196aKO cell lines
Six replicates of passage 10 imAPAD mir-196aKD, imAPAD-Con,
imGPAD mir-196aKD and imGPAD-Con pre-adipocytes were harvested
in Tri-reagent. Cells were harvested on day 3 after plating and were
sub-confluent. RNA was isolated using the mirVana miRNA Isolation
Kit (Life Technologies). RNA concentration was assessed using the
Nanodrop ND-1000 spectrophotometer and by RiboGreen® assay and
samples were normalised to give 100 ng RNA in a total volume of 11
μl. RNA quality was verified using the Agilent TapeStation (Agilent,
Santa Clara, US). RNA samples were reverse transcribed using the
Illumina TotalPrep-96RNAAmplification Kit and then converted into la-
belled cDNA using the IlluminaWhole-Genome Gene Expression Direct
Hybridisation Assay. The labelled ss-cDNA was then hybridized to two
HumanGene2.1 ST-16 Array Plates. The array was washed, stained and
scanned using the Affymetrix GeneTitan platform. Raw data were Ro-
bustmulti-array (RMA) normalised and checked for quality. Differential
expression analysis was performed in R [24].
Gene ontology (GO) enrichment analysis was performed in Data-
base for Annotation, Visualization, and Integrated Discovery (DAVID)
(http://www.david.niaid.nih.gov/ [26,27]) with the gene list from the
Affymetrix HumanGene2.1 ST-16 array as background. EASE score was
used to calculate enrichment for GO classifications. The default func-
tional annotation cluster function within DAVID was used to cluster re-
dundant or closely related GO terms together. The enrichment score for
each cluster is the geometric mean of the Bonferroni-corrected p-values
for the cluster. Transcripts were excluded from analysis if expression
was below background intensity in both conditions being compared.
3.6. Credible sets analysis
To generate credible sets of likely-causal variants at the HOXC locus,
we first identified all of the independent signals in the locus using ap-
proximate conditional testing in Genome-wide Complex Trait Analysis
(GCTA) [28] using the GIANT summary-level data in European-ancestry
samples only. Genotyping data from the PIVUS cohort (N = 949), in-
cluded in the GIANT analysis, was used as the reference dataset in the
GCTA analysis. Once we had identified the independent signals
contained in the locus, we performed conditional testing (also in
GCTA) to generate summary-level data for each signal. For example, to
generate summary-level data for independent signal A (index SNP
rs10783615), we conditioned on independent signals B (index SNP
rs1443512) and C (index SNP rs2071449) and then stored the resulting
summary-level statistics. We repeated this process for signals B and C.
We used the index SNPs as reported in the initial genome-wide associ-
ation study of WHR performed in GIANT [14]. Finally, once we had
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model as previously implemented in a genome-wide association study
of type 2 diabetes to determine the credible sets of likely-causal SNPs
in the region (for each of the sets of summary-level data). The analysis
results in a posterior likelihood for each SNP that the SNP is the causal
variant in the region.
We performed an identical analysis using the UK Biobank data. We
used the individual level genotypes from the UK Biobank as a reference
for the GCTA analyses, and used the same three SNPs as index SNPs for
conditional testing.
3.7. Statistical analyses
Statistical analyses were performed in SPSS 20.0 or 22.0. All p-values
are two-tailed.
3.8. Data sharing
Supplementary data for the microarray analysis of microRNAs in
ASAT tissue from 15 men, with paired gluteal adipose tissue from 8 of
the men (DOI: 10.17632/krgbnvxc5v.1) and for miR-196a KD in






































Fig. 1. a. Volcano plot showing qPCR validation data of selected differentially expressed miRNA
Positive log2 fold changes indicate higher expression in gluteal adipose tissue. Those that reta
196a expression in in vitro differentiated primary pre-adipocytes derived from ASAT and GS
in vitro differentiated imAPAD and imGPAD cell lines derived from ASAT and GSAT respectivelym4xtmzmx39.1) are available at Mendeley (https://data.mendeley.
com).
4. Results
4.1. MicroRNA-196a displays adipose tissue depot-specific expression
patterns
To assess the extent to which miRNAs may contribute to body fat
distribution, we performed microarray miRNA profiling of abdominal
subcutaneous adipose tissue (ASAT) from 15 men recruited from the
Oxford Biobank (OBB) (mean age 43∙8 years, 35–54 years; 8 lean (BMI
b 25 kg/m2) and 7 overweight (BMI N 25 kg/m2)) together with paired
gluteal subcutaneous adipose tissue (GSAT) from 4 lean and 4 over-
weight men. Of the 161 miRNAs included in the array and expressed
in AT, 32 reached the significance threshold (p = 0∙05) for differential
expression with a fold change of at least 20% (Table S1). Validation
qPCR was performed on paired ASAT and GSAT biopsies from an ex-
panded panel of 20 men and 20 women from the OBB and including
both lean and overweight BMI categories (Table S2). Twelve of the orig-
inal miRNAs remained significant after validation (Table S3, Fig. 1a).















s between gluteal and abdominal subcutaneous adipose tissue (n = 40 paired biopsies).
ined significance are indicated with name and their data is presented in Table S2. b. miR-
AT (n = 6; mean ± SE; *p b 0∙05, **p b 0∙005, paired t-test). c. miR-196a expression in
(n = 6; mean ± SE; * p b 0∙05, paired t-test).
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Fig. 2. a. miR-196a expression in paired ASAT and GSAT biopsies from age, sex and
genotype-balanced group of rs11614913 (n = 30 in each group), **p b 0∙005; t-test. b.
Folding and free energy of binding of miR-196a-2 containing the wild-type allele (top)
and minor allele (bottom), as predicted in M-fold.
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expression in GSAT (miR-196a: p = 9∙6 × 10−11; miR-204: p = 6∙2
× 10−8, paired t-test). MiR-196a is of particular interest because it is
foundwithin theHOXC13 locus, which has been linked toWHRadjusted
for BMI in large-scale genome-wide association studies [14,29]. Several
studies have demonstrated that miR-196a is necessary for embryonic
patterning [30–32]. Studies of miR-196a expression in other species
and non-adipose tissues have shown increasing expressionmoving dis-
tally along the anterio-posterior axis [31,33–35]. Further, miR-196a ap-
pears functional in human adipocytes: Mori et al. proposed that miR-
196a regulates brown adipogenesis of white AT lineage cells by
targeting HOXC8, which in turn regulates the adipogenic signal CEBPβ
[36]. In the expanded panel of 40 individualsmiR-196awas strongly dif-
ferent between ASAT and GSAT but was not influenced by obesity
(ASAT: p = 0∙18; GSAT: p = 0∙82, independent samples t-test). We
therefore hypothesised that miR-196a could have a functional role in
determining body fat distribution.
Further dissection of miR-196a expression in AT using the expanded
follow-uppanel of 40 individuals (Table S2) demonstrated itwas not in-
fluenced by sex (ASAT: p = 0∙55; GSAT: p = 0∙069, independent sam-
ples t-test). The depot-specific expression pattern of miR-196a was
seen in both men and women (Table S3).
We next performed in vitro differentiation time-courses of both pri-
mary pre-adipocytes and immortalised human pre-adipocytes derived
from ASAT and GSAT (termed imAPAD and imGPAD respectively [20]).
Expression of adipogenic transcription factors (PPARG2, CEBPA, CEBPB
and, CEBPD) and markers of terminal adipocyte differentiation (PLIN1,
INSR, ADIPOQ, CD36 and LPL) was similar for both primary and
immortalised differentiated pre-adipocytes derived from both depots,
although cells of GSAT origin accumulated significantlymore intracellu-
lar lipid (data shown in [20]). The miR-196a fat depot-specific expres-
sion pattern was maintained in vitro throughout differentiation in
both the primary adipocyte culture and in the immortalised cell lines
(Figs. 1b-c), suggesting that its expression pattern may be intrinsic to
the location-specific pre-adipocytes and not a function of the in vivo en-
vironment. MiR-196a was up-regulated during adipocyte differentia-
tion (Figs. 1b-c). Consistent with this finding, miR-196a expression
was 7∙1-fold higher in the mature adipocyte fraction compared with
the pre-adipocyte containing stromo-vascular fraction of AT. Within
an independent panel of 16 within-person paired samples obtained
from women undergoing bariatric surgery [17] expression of miR-
196a was extremely low in visceral AT (VAT) (25-fold lower, p = 5∙0
× 10−6; paired t-test) compared with ASAT, confirming the depot-
specific expression pattern. Additionally, miR-196a is highly expressed
in human AT compared to other tissues: a previous analysis of high-
throughput sequencing data from131 individuals from theMuTHER co-
hort [37] revealed that miR-196a expression was significantly higher in
ASAT than other human tissues except for 2 othermesenchymal tissues,
muscle and kidney.
The homeobox miR-196a target mRNAs HOXA5 [38], HOXB8 [33,39]
andHOXC8 [36,39,40] displayed reciprocal expressionwithmiR-196a in
the expanded panel of 40 individuals (HOXA5: 5-fold lower in GSAT vs
ASAT, p b 0∙001; HOXB8: 3-fold lower in GSAT, p = 0∙16; HOXC8: 2-
fold lower in GSAT, p b 0∙001). These patterns were maintained during
in vitro differentiation of primary pre-adipocytes and the immortalised
pre-adipocyte cell lines (Fig. S1).
There are three paralogues of the mir-196 gene located on differ-
ent chromosomes: mir-196a-1 and 2 transcribe the same mature
miRNA which cannot be distinguished by qPCR, but are derived from
unique precursor sequences; miR-196b differs from mir-196a-1 and
2 by one nucleotide. Pre-miR-196a-1 was not detected by qPCR in ei-
ther AT depot in the expanded panel (Table S2), whilst pre-miR-196a-
2 showed depot-specific expression mirroring mature miR-196a (n =
40, 2.4-fold higher in GSAT than ASAT, p = .006, Wilcoxon signed
rank test), which shows that miR-196a-2 is the predominant
paralogue in human AT.4.2. A SNP in pre-mir-196a-2, rs11614913, is associated with human body
fat distribution
Previous genome-wide efforts have used conditional association
testing to identify three independent signals for WHR adjusted for
BMI harboured within the HOXC locus (defined for simplicity as signals
A, B and C [14]). The sentinel SNP defining the C signal (rs2071449), is
within the LD block also containing the SNP rs11614913 which falls
within the pre-mir-196a gene region (linkage disequilibrium (r2) =
0.59 with rs2071449 indicating moderate linkage disequilibrium). To
investigate whether rs11614913 has any functional consequences and
is linked to the associations observed for this region we first confirmed
an association between rs11614913 and body fat distribution. Meta-
analysis data from the GIANT consortium [14] performed in 150,738 in-
dividuals revealed an association between WHR (adjusted for BMI and
age) and the minor allele (T) of rs11614913 (n = 141,414, beta (se)
= 0∙03 (0∙004), p = 6∙9 × 10−11) in both men (55,920, beta (se) =
0∙03 (0∙007), p = 2∙7 × 10−5) and women (n = 85,629, beta (se) =
0∙02 (0∙006), p = 1∙1 × 10−7). This was mediated by an expansion in
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473C. Hilton et al. / EBioMedicine 44 (2019) 467–475× 10−11; men: n = 60,340, beta (se) = 0∙03 (0∙007), p = 1∙2 × 10−6;
women: n = 90,592, beta (se) = 0∙03 (0∙005), p = 6∙8 × 10−8) rather
than an association with hip circumference (n = 142,467, beta (se) =
0∙0003 (0∙005), p = 0∙95; men: n = 56,413, beta (se) = 0∙004
(0∙007), p = 0∙53; women: n = 86,241, beta (se) = −0∙0016 (0∙006),
p = 0∙78). The association between the rs11614913 TT genotype and
WHR adjusted for BMI replicates in the UK Biobank sample [18] (n =
120,126, beta (se) = 0∙03 (0∙004), p = 1∙4 × 10−10; men: n = 56,863,
beta (se) = 0∙02 (0∙004), p = 3∙8 × 10−3; women: n = 63,308, beta
(se) = 0∙03 (0∙004), p = 1∙04 × 10−9). Furthermore, within the OBB
population rs11614913 was associated with lean mass of the arms (n
=4484, beta (se) =−0∙019 (0∙007), p = 0∙008) following adjustment
for age, gender, height squared and first four principal components. We
did not observe a significant association between rs11614913 genotype
and total lean mass (n = 4484, beta (se) = −0∙010 (0∙007), p = 0∙16)
or lean mass of the legs (n = 4484, beta (se) = −0∙0089 (0∙008), p =
0∙28), in keeping with the upper body regionality of the miR-196a AT
phenotype.
To further characterise the contribution of this complex region to the
observed WHR association, we used GIANT European-ancestry data (n
=136,154) and UK Biobank data (n=120,126) to perform conditional
testing on each of the three independent HOXC loci signals in each re-
spective dataset. Using a Bayesian-refinement approach [41], no single
SNP within the locus, including rs11614913, captured the bulk of the
posterior probability of being the causal SNP at the locus (Fig. S2). We
therefore analysed datasetswith better definition of human fat distribu-
tion using dual X-ray absorptiometry (DXA, GE Lunar iDXA). The stan-
dard output from this gives total android fat mass and calculated
visceral fat mass. The ASAT fat mass was calculated by subtracting vis-
ceral fatmass from total android fatmass. Analysis of the association be-
tween rs11614913 and defined fat depots in a cohort combining the
OBB, the UK Biobank, the EPIC-Norfolk and the Fenland cohort (in
total n = 24,010) showed that rs11614913 was specifically associated
with ASAT expansion (ASAT: n = 23,945 beta 0∙053 (se) = (0∙0093),
p = 1∙05 × 10−8, Table S4). We therefore investigated whether there
was a functional mechanism by which rs11614913 might be causal for
AT expansion.
4.3. rs11614913 is an eQTL for miR-196a in human adipose tissue
A separate earlier study including 70 individuals did not identify
rs11614913 as an eQTL for miR-196a [42], so to increase the power of
the observation of the minor allele (MAF = 0.405) carriers we per-
formed a genotype-balanced recruitment of 90 individuals from the
OBB matched for age, sex and BMI for rs11614913 genotypes (n = 30
of each genotypeCC, CT and TT, i.e. selective enrichment ofminor allele),
and determinedmiR-196a expression by qPCR in paired ASAT andGSAT
biopsies. Expression of miR-196a was lower in ASAT for TT carriers
(whole cohort: −32%, mean ddCT (se) TT = 0∙70 (0∙053) CC/CT =
1∙02 (0∙098), p = 0∙005, t-test; Fig. 2.a; men: −25%, p = 0∙011;
women: −34%, p = 0∙18), consistent with a recessive effect, but not
quite statistically significant in GSAT (−8%, mean ddCT (se) TT = 1∙88
(0∙16), CC/CT = 2∙05 (0∙19), p = 0∙061, t-test, men: −9%, p = 0∙38;
women: −10%, p = 0∙089) which has the higher overall expression.
We saw no difference in levels of HOXA5, HOXB8 or HOXC8 between ge-
notype groups in the panel of 90 individuals (CC/CT vs TT; ASATHOXA5:
p = 0∙76; GSAT HOXA5: 1∙15-fold, p = 0∙24; ASAT HOXB8: 0∙81-fold, p
= 0∙70; GSAT HOXB8: 0∙84-fold, p = 0∙08; ASAT HOXC8:0∙94-fold, p =
0∙66; GSAT HOXC8: 0∙99-fold, p = 0∙97). However, within the larger
MuTHER dataset [43] rs11614913 TT genotype was associated withFig. 3. a. Expression of miR-196a in imGPAD and imAPAD cell lines following transduction of mi
protein in HEK293 cell lines following transduction ofmiR-196aKD or control vector (*p b 0∙05;
transduction of miR-196aKD or control vector, **p b 0∙005. d. Light microscopy (x10magnificat
vector after 14 days of in vitro differentiation. e.mRNA expression of PPARγ2 and CEBPα through
biopsies from age, sex and genotype-balanced group of rs11614913 (n = 30 in each group).increased HOXC8 expression in ASAT (n = 856, beta = 0∙043, p =
0∙015). Within the panel of 90 individuals there was no effect of the ge-
notype on pre-miR-196a-2 expression (ASAT: p= 0∙43Mann-Whitney
U test; GSAT: p=0∙17,Mann-WhitneyU test), suggesting that the effect
of the T allele is occurring post-transcriptionally at the level of pre-
miRNA processing. The rs11614913 is within the pre-miR-196a-2; in
silico modelling of pre-miR-196a-2 in M-fold [44] predicted that the
rs11614913 C to T transition would increase the free energy of binding
(ΔG) of the precursor hairpin from −51∙20 to −46∙60 kCal/mol,
destabilising it (Fig. 2b).We therefore predicted that the reduced stabil-
ity of the minor T allele precursor would reduce the efficiency of cleav-
age of pre-miR-196a-2.
4.4. miR-196a is a negative modulator of proliferation of both abdominal
subcutaneous and gluteal preadipocytes
To investigate if miR-196a influences adipogenesis we generated
stable miR-196a knock down (KD) cell lines by lentiviral transduction
from immortalised pre-adipocyte cell lines (imAPAD and imGPAD),
which are derived from ASAT and GSAT respectively [20]. miR-
196aKD led to decreasedmiR-196a expressionmirroring themagnitude
of difference between rs11614913 TT and CC/CT genotypes (Fig. 3a). As
a functional proof-of-concept, the corresponding KD of miR-196a in the
HEK293 cell line showed increased protein and gene expression of the
established miR-196a target HOXC8 [36,40] (Fig. 3.b). The miR-196a
KD led to a reduced proliferation rate (increased doubling time) of
pre-adipocytes of both ASAT and GSAT origin (Fig. 3c; imAPAD-mir-
196aKD vs imAPAD-Con = 9∙5%, p = 0∙002; imGPAD-mir196aKD vs
imGPAD-Con=12∙3%, p=0∙002). Therewas no difference in adipogen-
esis of control vs. miR-196aKD pre-adipocytes, as determined by mi-
croscopy (Fig. 3d), CEBPa and PPARy expression (Fig. 3e) or cellular
lipid (adipoRed) accumulation (imAPAD mir-196aKD vs imAPAD-Con:
n = 6, p = 0∙38, paired t-test; imGPAD mir-196aKD vs imGPAD-Con: n
= 6, p = 0∙78, paired t-test). These data suggest that lower miR-196a
expression reduces the tissue adipocyte cellularity via adipocyte hyper-
trophy rather than hyperplasia. Histological examination ofwhole ASAT
biopsieswas consistentwith this: in ASAT needle biopsies from an inde-
pendent cohort [19] the mean adipocyte volume in ASAT was 3∙0%
greater in male rs11614913 homozygous TT carriers (associated with
reduced miR-196a ASAT expression) after adjustment for age and BMI
(n = 81, beta = 0∙15, p = 0∙019), but not in women (n = 232, beta
= 0∙018, p = 0∙64).
4.5. Transcriptome analysis reveals thatmiR-196a regulates genes involved
in extracellular matrix pathways
To identify AT features that would sustain the observed adipocyte
hypertrophywe performedmicroarray profiling of imAPAD and imGPAD
pre-adipocytes transduced with control or miR-196a KD vector. Pre-
adipocytes were harvested on day 3 after plating and were sub-
confluent. Gene ontology (GO) enrichment analysis of 441 annotated
transcripts significantly regulated between imGPAD miR-196aKD and
imGPAD-Con demonstrated a significant enrichment for GO terms re-
lated to extracellular matrix (ECM) and vascular development
(Benjamini-Hochberg adjusted data) (Table 1), suggesting a role for
miR-196a in AT structure and remodelling. The number of annotated
transcripts regulated by miR-196aKD in the imAPAD cell line was
lower (Table 1, column 2) but the transcripts with the greatest fold-
changes were also enriched for GO terms relating to ECM (Table 1, col-
umn 3). We identified COL25A1, which is a key ECM component, asR-196aKD or control vector (*p b 0∙05 **p b 0∙005; paired t-test). b. miR-196a and HOXC8
paired t-test). c. Preadipocyte doubling time of the imGPAD and imAPAD cell lines following
ion) of the imGPAD and imAPAD cell lines following transduction of miR-196aKD or control
out the 14-day differentiation time-course. f. COL25A1 expression in paired ASAT andGSAT
Table 1
Gene ontology terms with significant enrichment for annotated transcripts.
imGPAD -196aKD versusimGPAD-Con imAPAD -196aKD versusimAPAD-Con imAPAD -196aKD versusimAPAD-Con: based on
transcripts with N 50% fold change and
significance p b 0∙01
(n = 441 transcripts) (n = 22 transcripts) (n = 47 transcripts)
Gene ontology terms Enrichment
score
Gene ontology terms Enrichment
score
Gene ontology terms Enrichment
score
Extracellular matrix 9∙14 Inflammation and immune response 2∙92 Extracellular region 3∙26
Vasculature development 6∙98 Interleukin 1 1∙85 Hormone, amidation 2∙00
EGF-like region 6∙48 Positive regulation of macromolecule biosynthetic
process
1∙76 Extracellular matrix 1∙83
EGF‑calcium binding 5∙36 Acute inflammatory response 1∙74 Cell motility 1∙42
Cell migration 5∙17 Leucine-rich repeat 1∙67 Negative regulation of
transcription
1∙41





Positive regulation of transcription 3∙05
Regulation of apoptosis 2∙53
474 C. Hilton et al. / EBioMedicine 44 (2019) 467–475strongly up-regulated by miR196aKD in both imGPAD and imAPAD cell
lines. This finding was related back to the paired ASAT and GSAT biop-
sies from the genotype-balanced recruitment of 30 age, sex and BMI-
matched individuals which showed 30∙1% higher expression of
COL25A1 in rs11614913 TT carriers (though, possibly due to available
sample size, the finding was not quite statistically significant: p = .06)
indicating that reduced abundance of miR196a may affect matrix ex-
pression in vivo (Fig. 3f). MiR-196a dysregulation has been observed
in scleroderma [45,46] and keloid scarring [47], both pathologies
underpinned by ECM abnormalities. Functional studies have shown
thatmiR-196a inhibits production of type I [45–47] and type III collagen
[47]. In addition to providing a structuralmatrix for AT, ECMplays a role
in determining the ability of AT to expand [48]. Thus, appropriately con-
figured ECM is necessary for in vivo adipogenesis [49], whilst excessive
accumulation of ECM components can restrict AT expansion [48].5. Discussion
The MIR196A gene lies within the LD block defined by rs2071449,
which is an intronic SNP within HOXC4 and C5, and the sentinel SNP
for the WHR adjusted for BMI phenotype association in the region
[14]. We showed that rs11614913 may have direct impact on the pro-
cessing of the pre-mir-196a-2 and functional work identified that ho-
mozygote carriers have an altered cellular phenotype. This study is the
first to provide a causal mechanism linking to human fat distribution
and distinct fat depot expansion at the HOXC locus. It should be noted
that the populations used in these studies were almost exclusively of
European ancestry, and further studies will be required to validate
these findings in other populations. Men and women have markedly
different body fat distribution.Whilst rs11614913 is associated with in-
creased WHR in both sexes, the association between rs11614913 and
adipocyte size was significant in men only. Therefore, in vitro miR-
196aKD experiments were conducted using immortalised pre-
adipocytes from a male donor. Further work is indicated to determine
whether there is sexual dimorphism in the actions of miR-196a.
In conclusion, miR-196a, which shows strong AT depot-specific ex-
pression, is under genetic influence and exerts a regulatory effect on
AT structure and human body fat distribution by affecting the tran-
scriptome for ECM.
Table 1: Gene ontology terms with significant enrichment for anno-
tated transcripts differentially expressed between imGPAD -196aKD and
imGPAD-Con cell lines and between imAPAD -196aKD and imAPAD-Con
cell lines, after Benjamini-Hochberg correction for multiple testing(p b 0∙05). Column 3 refers to annotated transcripts differentially
expressed between imAPAD -196aKD and imAPAD-Control cell lines
with a fold change N50% and an unadjusted significance of p b 0∙01.
The enrichment score for each cluster is the geometric mean of the
Bonferroni-corrected p-values for the cluster.
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